Pasar al contenido principal

COOPERACION ENTRE MODIFICADORES DE LA CROMATINA PARA REGULAR LA ACTIVIDAD DE ENHANCERS DURANTE LA DIFERENCIACION CELULAR

BFU2014-53543-P

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chromatin structure and pre-mRNA processing work together

  • Jimeno-González, Silvia
  • Reyes, José C.
Chromatin is the natural context for transcription elongation. However, the elongating RNA polymerase II (RNAPII) is forced to pause by the positioned nucleosomes present in gene bodies. Here, we briefly discuss the current results suggesting that those pauses could serve as a mechanism to coordinate transcription elongation with pre-mRNA processing. Further, histone post-translational modifications have been found to regulate the recruitment of factors involved in pre-mRNA processing. This view highlights the important regulatory role of the chromatin context in the whole process of the mature mRNA synthesis., Work in the Silvia Jimeno-González and José C. Reyes laboratory was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) [Grants number BFU-2011-23442 and BFU2014-53543-P] and Andalusian Government [P06-CVI-4844]., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage

  • Guijo, Macarena
  • Ceballos-Chávez, María
  • Gómez-Marín, Elena
  • Basurto-Cayuela, Laura
  • Reyes, José C.
Tudor domain containing protein 9 (TDRD9) is a RNA helicase normally expressed in the germline, where it is involved in the biosynthesis of PIWI-interacting RNAs (piRNAs). Here, we show that TDRD9 is highly expressed in a subset of non-small cell lung carcinomas and derived cell lines by hypomethylation of its CpG island. Furthermore, TDRD9 expression is associated with poor prognosis in lung adenocarcinoma. We find that downregulation of TDRD9 expression in TDRD9-positive cell lines causes a decrease in cell proliferation, S-phase cell cycle arrest, and apoptosis. Transcriptomic analysis demonstrated that TDRD9 knockdown causes upregulation of cell cycle and DNA repair genes. We also observed that TDRD9 knockdown triggers activation of the catalytic subunit of the DNA dependent protein kinase (DNA-PKcs) and phosphorylation of H2A.X, which are indicative of an increase of DNA double strand breaks. TDRD9- silenced cells also presented aberrant mitosis and abnormal-shaped nuclei indicating defects in chromosomal segregation. Finally, TDRD9 silencing caused hypersensitivity to the replication stress inducer aphidicolin, while overexpression of the protein increased resistance to the drug, suggesting that TDRD9 protects from replicative stress to TDRD9-positive tumor cells. Thus, our results place TDRD9 as a marker for prognosis and as a potential therapeutic target in a subset of lung carcinomas., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P to J.C. Reyes), the Junta de Andalucía (BIO-321) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Analysis of the relationship between coexpression domains and chromatin 3D organization

  • Soler-Oliva, María E.
  • Guerrero-Martínez, José A.
  • Bachetti, Valentina
  • Reyes, José C.
Gene order is not random in eukaryotic chromosomes, and co-regulated genes tend to be clustered. The mechanisms that determine co-regulation of large regions of the genome and its connection with chromatin three-dimensional (3D) organization are still unclear however. Here we have adapted a recently described method for identifying chromatin topologically associating domains (TADs) to identify coexpression domains (which we term “CODs”). Using human normal breast and breast cancer RNA-seq data, we have identified approximately 500 CODs. CODs in the normal and breast cancer genomes share similar characteristics but differ in their gene composition. COD genes have a greater tendency to be coexpressed with genes that reside in other CODs than with non-COD genes. Such inter-COD coexpression is maintained over large chromosomal distances in the normal genome but is partially lost in the cancer genome. Analyzing the relationship between CODs and chromatin 3D organization using Hi-C contact data, we find that CODs do not correspond to TADs. In fact, intra-TAD gene coexpression is the same as random for most chromosomes. However, the contact profile is similar between gene pairs that reside either in the same COD or in coexpressed CODs. These data indicate that co-regulated genes in the genome present similar patterns of contacts irrespective of the frequency of physical chromatin contacts between them., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) [BFU-2011-23442 and BFU2014-53543-P to JCR], Junta de Andalucía (BIO0321), and the European Union (FEDER). CABIMER is supported by Junta de Andalucía. MESO received an Asociación Española Contra el Cáncer (AECC) summer fellowship; VB received a Leonardo da Vinci fellowship from the European Community., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Histone availability as a strategy to control gene expression

  • Prado, Félix
  • Jimeno-González, Silvia
  • Reyes, José C.
Histone proteins are main structural components of the chromatin and major determinants of gene regulation. Expression of canonical histone genes is strictly controlled during the cell cycle in order to couple DNA replication with histone deposition. Indeed, reductions in the levels of canonical histones or defects in chromatin assembly cause genetic instability. Early data from yeast demonstrated that severe histone depletion also causes strong gene expression changes. We have recently reported that a moderated depletion of canonical histones in human cells leads to an open chromatin configuration, which in turn increases RNA polymerase II elongation rates and causes pre-mRNA splicing defects. Interestingly, some of the observed defects accompany the scheduled histone depletion that is associated with several senescence and aging processes. Thus, our comparison of induced and naturally-occurring histone depletion processes suggests that a programmed reduction of the level of canonical histones might be a strategy to control gene expression during specific physiological processes., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) [BFU-2011-23442 and BFU2014-53543-P to J.C.R.] and the Andalusian Government [P12CT52270 to F.P.]., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer

  • Guerrero-Martínez, José A.
  • Reyes, José C.
The gene encoding the ATPase of the chromatin remodeling SWI/SNF complexes SMARCA4 (BRG1) is often mutated or silenced in tumors, suggesting a role as tumor suppressor. Nonetheless, recent reports show requirement of SMARCA4 for tumor cells growth. Here, we performed a computational meta-analysis using gene expression, prognosis, and clinicopathological data to clarify the role of SMARCA4 and the alternative SWI/SNF ATPase SMARCA2 (BRM) in cancer. We show that while the SMARCA4 gene is mostly overexpressed in tumors, SMARCA2 is almost invariably downexpressed in tumors. High SMARCA4 expression was associated with poor prognosis in many types of tumors, including liver hepatocellular carcinoma (LIHC), and kidney renal clear cell carcinoma (KIRC). In contrast, high SMARCA2 expression was associated with good prognosis. We compared tumors with high versus low expression of SMARCA4 or SMARCA2 in LIHC and KIRC cohorts from The Cancer Genome Atlas. While a high expression of SMARCA4 is associated with aggressive tumors, a high expression of SMARCA2 is associated with benign differentiated tumors, suggesting that SMARCA4 and SMARCA2 play opposite roles in cancer. Our results demonstrate that expression of SMARCA4 and SMARCA2 have a high prognostic value and challenge the broadly accepted general role of SMARCA4 as a tumor suppressor., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2014-53543-P to J.C.R.], Junta de Andalucía (BIO-0321), and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TBL1 is required for the mesenchymal phenotype of transformed breast cancer cells

  • Rivero, Sabrina
  • Gómez-Marín, Elena
  • Guerrero-Martínez, José A.
  • García-Martínez, Jorge
  • Reyes, José C.
The epithelial-to-mesenchymal transition (EMT) and its reversion (MET) are related to tumor cell dissemination and migration, tumor circulating cell generation, cancer stem cells, chemoresistance, and metastasis formation. To identify chromatin and epigenetic factors possibly involved in the process of EMT, we compare the levels of expression of epigenetic genes in a transformed human breast epithelial cell line (HMEC-RAS) versus a stable clone of the same cell line expressing the EMT master regulator ZEB1 (HMEC-RAS-ZEB1). One of the factors strongly induced in the HMEC-RAS-ZEB1 cells was Transducin beta-like 1 (TBL1), a component of the NCoR complex, which has both corepressor and coactivator activities. We show that TBL1 interacts with ZEB1 and that both factors cooperate to repress the promoter of the epithelial gene E-cadherin (CDH1) and to autoactivate the ZEB1 promoter. Consistent with its central role, TBL1 is required for mesenchymal phenotypes of transformed breast epithelial and breast cancer cell lines of the claudin-low subtype. Importantly, a high expression of the TBL1 gene correlates with poor prognosis and increased proportion of metastasis in breast cancer patients, indicating that the level of TBL1 expression can be used as a prognostic marker., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C.R.), the Junta de Andalucía (BIO-321), and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, José A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiró, Sandra
  • Reyes, José C.
The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Regulation of enhancers, co-expression domains and splicing efficiency by TGFß

  • Guerrero-Martínez, José A.
  • Sánchez-Escabias, Elena
  • Gómez-Marín, Elena
  • Basurto-Cayuela, Laura
  • Pozuelo-Sánchez, Isabel
  • Ceballos-Chávez, María
  • Reyes, José C.
Resumen del trabajo presentado en la I Reunión de la Red de Excelencia Temática, celebrada en Sevilla (España), los días 12 y 13 de julio de 2021, TGFβ cytokines have crucial roles in development, proliferation, tissue homeostasis, differentiation and immune regulation. Consequently, alterations in TGFβ signaling underlie numerous diseases, including cancer. TGFβ is one of the most potent inductors of epithelial to mesenchymal transition (EMT) in normal and oncogenic epithelial cells from different origins. EMT and its reversion (MET) are common processes during embryonic development and have attracted considerable interest due to the fact that they seem to be related to tumor cells dissemination and migration, generation of tumor circulating cells, cancer stem cells and metastasis formation. TGFβ causes a large reorganization of gene expression patterns and epigenetic information, that we are only starting to understand. In our group we are investigating how TGFβ causes these reorganization of gene expression patterns. We have cartographied the genomic transcriptional enhancers that are regulated by TGFβ in a breast epithelial cell line. In fact, TGFβ triggers a fast and widespread increase in chromatin accessibility in about 80% of enhancers, irrespective of whether they are activated, repressed or not regulated by TGFβ. We have also shown that most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). We are currently investigating how the 3D organization of the genome connect the enhancers with the TRDs. We have also investigated whether regulation co-transcriptional splicing efficiency at the whole gene level is used to regulate gene expression by TGFβ. First we found that the existence of two well-differentiated strategies for co-transcriptional splicing efficiency, at the extremes of a gradient: short genes, that produces high levels of pre-mRNA display a relatively inefficient splicing while long genes with relatively low pre-mRNA levels present efficient splicing. Furthermore, we found that the TGFβ pathway regulates the general co-transcriptional splicing efficiency causing changes in mature mRNA levels. Taken together, our data indicate that co-transcriptional splicing efficiency is a gene-specific characteristic that can be regulated to control gene expression. Finally, other members of the group are looking for chromatin factors that control gene expression changes caused by TGFβ., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R), by Junta de Andalucía (P18-FR-1962) and by Fundación Vencer el Cáncer (VEC – 001/2014 FVEC-FPS)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Defective histone supply causes changes in RNA polymerase II elongation rate and co-transcriptional pre-mRNA splicing

  • Jimeno-González, Silvia
  • Payán-Bravo, Laura
  • Muñoz-Cabello, Ana M.
  • Guijo, Macarena
  • Gutiérrez, Gabriel
  • Prado, Félix
  • Reyes, José C.
RNA polymerase II (RNAPII) transcription elongation is a highly regulated process that greatly influences mRNA levels as well as pre-mRNA splicing. Despite many studies in vitro, how chromatin modulates RNAPII elongation in vivo is still unclear. Here, we show that a decrease in the level of available canonical histones leads to more accessible chromatin with decreased levels of canonical histones and variants H2A.X and H2A.Z and increased levels of H3.3. With this altered chromatin structure, the RNAPII elongation rate increases, and the kinetics of pre-mRNA splicing is delayed with respect to RNAPII elongation. Consistent with the kinetic model of cotranscriptional splicing, the rapid RNAPII elongation induced by histone depletion promotes the skipping of variable exons in the CD44 gene. Indeed, a slowly elongating mutant of RNAPII was able to rescue this defect, indicating that the defective splicing induced by histone depletion is a direct consequence of the increased elongation rate. In addition, genome-wide analysis evidenced that histone reduction promotes widespread alterations in pre-mRNA processing, including intron retention and changes in alternative splicing. Our data demonstrate that pre-mRNA splicing may be regulated by chromatin structure through the modulation of the RNAPII elongation rate., This work was funded by Spanish Ministry of Economy and Competitiveness (MINECO) Grants BFU-2011-23442 and BFU2014-53543-P (to J.C.R.) and Andalusian Government Grant P12CT52270 (to F.P.). S.J.-G. and A.M.M.-C. were supported by Juan de la Cierva Grants from MINECO. L.P.-B. was supported by the Asociación Española Contra el Cáncer.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, Jose A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiro Sales, Sandra
  • Reyes, Jose C.
Cromatina; Informàtica del genoma; Transcripció, Cromatina; Informática del genoma; Transcripción, Chromatin; Genome informatics; Transcription, The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, Jose A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiro Sales, Sandra
  • Reyes, Jose C.
Cromatina; Informàtica del genoma; Transcripció, Cromatina; Informática del genoma; Transcripción, Chromatin; Genome informatics; Transcription, The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation.